Results 31 to 40 of about 65,782,767 (266)

Predictive value of HFA-PEFF score in patients with heart failure with preserved ejection fraction [PDF]

, 2021
HFA-PEFF score has been proposed for diagnosing heart failure with preserved ejection fraction (HFpEF). Currently, there are only a limited number of tools for predicting the prognosis.
Zhang, Yanli, Tse, Gary, Liu, Ying, Sun, Yuxi, King, Emma, Xia, Yunlong, Li, Jiaxin, Dai, Mengyuan, Zhang, Xinxin, Si, Jinping   +9 more
core   +1 more source

Biomarkers in Heart Failure with Preserved Ejection Fraction

Cardiac Failure Review, 2022
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous disorder developing from multiple aetiologies with overlapping pathophysiological mechanisms.
Antoni Bayes-Genis, Germán Cediel, Mar Domingo, Pau Codina, Evelyn Santiago, Josep Lupón   +5 more
doaj   +1 more source

Pulmonary Vascular Pressures and Gas Exchange Response to Exercise in Heart Failure With Preserved Ejection Fraction

, 2020
Elevated left ventricular filling pressure (measured as mean pulmonary capillary wedge pressure) at rest or with exercise is diagnostic of heart failure with preserved ejection fraction.
Borlaug, BA, Johnson, BD, Fermoyle, CC, Stewart, GM   +3 more
core   +1 more source

Characteristics and outcomes of heart failure with recovered left ventricular ejection fraction [PDF]

, 2021
Aims There is an emerging interest in elucidating the natural history and prognosis for patients with heart failure with reduced ejection fraction (HFrEF) in whom left ventricular ejection fraction (LVEF) subsequently improves.
Zhang, Yanli, Liu, Ying, Sun, Yuxi, Chen, Feifei, Xia, Yunlong, Yang, Jing, Li, Xiao, Li, Jiaxin, Zhang, Xinxin, Dai, Mengyuan, Si, Jinping, Tse, G.   +11 more
core   +1 more source

Geographical Variations in Patients with Heart Failure and Preserved Ejection Fraction: A Sub-Group Analysis of the APOLLON Registry

Balkan Medical Journal, 2019
Background: Clinical characteristics of patients with heart failure may vary geographically. However, limited data are available regarding the geographical differences of patients with heart failure and preserved ejection fraction.
Bülent Özlek, Eda Özlek, Hicaz Zencirkıran Ağuş, Mehmet Tekinalp, Serkan Kahraman, Oğuzhan Çelik, Cem Çil, Özcan Başaran, Volkan Doğan, Bedri Caner Kaya, İbrahim Rencüzoğulları, Altuğ Ösken, Lütfü Bekar, Mustafa Ozan Çakır, Yunus Çelik, Kadir Uğur Mert, Kadriye Memiç Sancar, Samet Sevinç, Gurbet Özge Mert, Murat Biteker   +19 more
doaj   +1 more source

Transcriptomic Research in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives [PDF]

, 2020
Heart failure with preserved ejection fraction (HFpEF) is increasing in incidence and has a higher prevalence compared with heart failure with reduced ejection fraction.
Markus Scholz, Philipp Lurz, Karl-Philipp Rommel, Sebastian Rosch, Holger Thiele   +4 more
core   +1 more source

The value of IGF-1 and IGFBP-1 in patients with heart failure with reduced, mid-range, and preserved ejection fraction [PDF]

, 2022
Background: Previous studies have reported inconsistent results regarding the implications of deranged insulin-like growth factor 1 (IGF-1)/insulin-like growth factor-binding protein 1 (IGFBP-1) axis in patients with heart failure (HF).
Tse, Gary, Liu, Tong, Gong, Mengqi, Li, Guangping, Chen, Kang-Yin, Guo, Shaohua   +5 more
core   +1 more source

Heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus: pathophysiology and treatment options

Медицинский вестник Юга России, 2021
Type 2 diabetes mellitus is known to increase the risk of the development of heart failure with preserved ejection fraction and worsen its symptoms. To date, no specific treatment has been shown to reduce morbidity and mortality in patients with heart ...
A. A. Borisov, A. D. Gvozdeva, F. T. Ageev   +2 more
doaj   +1 more source

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes

Biomolecules, 2020
Heart Failure (HF) is a syndrome, which implies the existence of different phenotypes. The new categorization includes patients with preserved ejection fraction (HFpEF), mid-range EF (HFmrEF), and reduced EF (HFrEF) but the molecular mechanisms involved ...
Valeria Conti, Graziamaria Corbi, Maria Vincenza Polito, Michele Ciccarelli, Valentina Manzo, Martina Torsiello, Emanuela De Bellis, Federica D’Auria, Gennaro Vitulano, Federico Piscione, Albino Carrizzo, Paola Di Pietro, Carmine Vecchione, Nicola Ferrara, Amelia Filippelli   +14 more
doaj   +1 more source

Sodium-Glucose Co-transporter-2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Breakthrough in Improvement of Clinical Outcomes?

, 2022
The conventional conception of the therapy of heart failure (HF) with reduced ejection fraction has been recently modified by adding sodium-glucose co-transporter-2 (SGLT2) inhibitors to the combination consisting of beta blockers, mineralocorticoid ...
Alexander A. Berezin, Alexander E. Berezin   +1 more
core   +1 more source